Trials / Completed
CompletedNCT02778243
Sexual Steroids: Relationship Between Serum and Prostatic Tissue Level
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 107 (actual)
- Sponsor
- Hopital Foch · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients followed in the Foch Hospital Urology Department (Suresnes): Patients justifying a prostatectomy. * Patients justifying prostatectomy together with the bladder (radical cystectomy for bladder cancer). * Patients with benign prostate hyperplasia who justified a prostatectomy. Compare serum sexual steroid concentrations and intra-tissue on healthy prostates and prostate adenoma, assess concentrations intra-tissue sex steroids on cancer metastasis prostate specific blood sample under study (30mL) will be performed preoperatively in Patients followed in Foch Hospital Urology Department (Suresnes), and a Removal of a fragment of prostate tissue or metastasis will be analyze. Aim is to compare serum concentrations of sexual steroids and intra-tissue on healthy prostates and prostate adenomas compared to concentrations measured in patients operated for prostate cancer.
Detailed description
Steroids concentration will be determined using Gas chromatography-mass spectrometry. The analyzed steroids are : FSH :Mul/ml LH: mUI/ml SHBG: µg/ml BT: ng/ml TT: ng/ml DHT: ng/ml DHEA: ng/ml D5: ng/ml D4: ng/ml E1: pg/ml E2 : pg/ml DHEA-S : µg/dl
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | steroids concentrations determination |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2016-11-12
- Completion
- 2016-11-12
- First posted
- 2016-05-19
- Last updated
- 2017-06-14
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02778243. Inclusion in this directory is not an endorsement.